What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to disclose that Anthem's officers will be meeting with securities analysts and investors and to confirm the company's expectation to meet its previously announced earnings guidance.

When were the original earnings expectations set?

The original earnings expectations were set on April 30, 2003, through a press release and conference call.

What are some of the risks mentioned that could impact future performance?

The filing mentions several risks including rising healthcare costs and utilization rates, the company's ability to secure sufficient premium rate increases, increased government regulation, competition, new prescription drugs and technology, financial strength rating downgrades, increased debt levels, litigation, successful integration of acquisitions like Trigon Healthcare, Inc., and general economic downturns.

What does 'Regulation FD Disclosure' mean for investors?

Regulation FD (Fair Disclosure) means that when a company publicly releases material information, it must do so in a way that provides broad, non-exclusionary public access. In this case, the company is ensuring that its confirmation of meeting earnings expectations is made public, preventing selective disclosure to certain analysts or investors.

ELV 8-K SEC Disclosure

Summary

This 8-K filing by Anthem, Inc. (now Elevance Health) from June 9, 2003, serves as a Regulation FD disclosure. The company's officers are scheduled to meet with securities analysts and investors during the weeks of June 9th and June 16th, 2003. The primary purpose of these meetings is to reaffirm the company's ability to meet the previously issued earnings expectations established on April 30, 2003, via a press release and conference call. This confirmation signals a level of confidence from management regarding the company's financial performance in the near term.

Key Highlights

1Anthem, Inc. (ELV) reaffirmed its ability to meet previously stated earnings expectations.
2Management communicated this reaffirmation in preparation for upcoming meetings with securities analysts and investors.
3The confirmation is intended to provide assurance to the market regarding the company's financial outlook.
4The underlying earnings expectations were originally set on April 30, 2003, via press release and conference call.
5The filing includes a cautionary statement regarding forward-looking statements, highlighting potential risks and uncertainties.
6Key risks mentioned include trends in healthcare costs, premium rate increases, regulatory changes, and integration of acquisitions (specifically Trigon Healthcare, Inc.).

Elevance Health, Inc. 8-K Report (Jun 9, 2003)

Summary

Key Highlights

Frequently Asked Questions